The effect of orlistat versus metformin on body composition and insulin resistance in obese premenopausal women: 3-month randomized prospective open-label study-Reference-Cited by-同舟云学术

The effect of orlistat versus metformin on body composition and insulin resistance in obese premenopausal women: 3-month randomized prospective open-label study

Published:2017 Issue: Volume:4 Page:725-731
ISSN:1734-1922
Container-title:Archives of Medical Science
language:
Short-container-title:aoms

Author:

Kujawska-Łuczak Magdalena,Musialik Katarzyna,Szulińska Monika,Swora-Cwynar Ewelina,Kargulewicz Angelina,Grzymisławska Małgorzata,Pupek-Musialik Danuta,Bogdański Paweł

Publisher

Termedia Sp. z.o.o.

Subject

General Medicine

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of orlistat in obese patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials;Baylor University Medical Center Proceedings;2024-04-09

2. The impact of metformin on weight and metabolic parameters in patients with obesity: A systematic review and meta‐analysis of randomized controlled trials;Diabetes, Obesity and Metabolism;2024-03-11

3. Protective and Therapeutic Effects of Orlistat on Metabolic Syndrome and Oxidative Stress in High-Fat Diet-Induced Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) in Rats: Role on Nrf2 Activation;Veterinary Sciences;2021-11-12

4. POCU1b, the n-Butanol Soluble Fraction of Polygoni Cuspidati Rhizoma et Radix, Attenuates Obesity, Non-Alcoholic Fatty Liver, and Insulin Resistance via Inhibitions of Pancreatic Lipase, cAMP-Dependent PDE Activity, AMPK Activation, and SOCS-3 Suppression;Nutrients;2020-11-24

5. Lipid Hydrolase Enzymes: Pragmatic Prolongevity Targets for Improved Human Healthspan?;Rejuvenation Research;2020-04-01